Your browser doesn't support javascript.
loading
Initial Experience with the Derivo 2Heal Flow Diverter under Standard or Reduced-Dose Single Antiplatelet Therapy.
Uysal, Aycan; Cay, Ferdi; Balci, Sinan; Arat, Anil.
Afiliação
  • Uysal A; From the Hacettepe University Faculty of Medicine (A.U., F.C., S.B, A.A.), Ankara, Turkey.
  • Cay F; From the Hacettepe University Faculty of Medicine (A.U., F.C., S.B, A.A.), Ankara, Turkey.
  • Balci S; From the Hacettepe University Faculty of Medicine (A.U., F.C., S.B, A.A.), Ankara, Turkey.
  • Arat A; From the Hacettepe University Faculty of Medicine (A.U., F.C., S.B, A.A.), Ankara, Turkey anilarat@hotmail.com.
AJNR Am J Neuroradiol ; 45(8): 1038-1043, 2024 Aug 09.
Article em En | MEDLINE | ID: mdl-39025640
ABSTRACT
BACKGROUND AND

PURPOSE:

Flow diverters with surface modifications or coatings have been recently introduced to clinical practice with the expectation that they can reduce the rate of thromboembolic complications and residual aneurysms. The purpose of this study is to evaluate the utility of the Derivo 2Heal (D2H) device, a new fibrin and heparin-coated flow diverter. MATERIALS AND

METHODS:

Patients treated by a single operator by using the D2H were retrospectively evaluated for demographic data, aneurysm characteristics, procedural variables, and follow-up data. All patients were treated by using a single D2H, monitored by platelet function testing and kept under single antiplatelet therapy with regular or half-dose clopidogrel or prasugrel after the procedure.

RESULTS:

Twenty patients with 26 aneurysms were treated. Three presented acutely with subarachnoid hemorrhage. Adjunctive devices were used in 6 patients. There were no technical failures and 2 periprocedural self-limited nonthrombotic minor adverse events. During follow-up, 1 of the acutely ruptured aneurysms reruptured, and 1 patient had a visual TIA. All patients were doing well clinically (19 with mRS of 0 and 1 with 1) at the last follow-up after discharge. The rates of total occlusion on very early angiographic (MRA/CTA or DSA, mean 2.4 months), DSA (mean 5.8 months), and midterm angiographic (mean 14.5 months) follow-up for all versus uncoiled aneurysms were 68% versus 70%, 77.8% versus 90.0%, and 91.7% versus 90.1%, respectively.

CONCLUSIONS:

The absence of permanent neurologic deficits in the periprocedural period and favorable occlusion rates in this preliminary study suggest that the novel coating comprising fibrin and heparin may have the potential to increase the safety and efficacy of flow diversion and needs to be further studied by comparing the D2H device with its bare counterpart and other coated or surface-modified flow diverters.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Aneurisma Intracraniano Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: AJNR Am J Neuroradiol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Turquia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Aneurisma Intracraniano Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: AJNR Am J Neuroradiol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Turquia
...